000165932 001__ 165932
000165932 005__ 20240229133515.0
000165932 0247_ $$2doi$$a10.1111/add.15335
000165932 0247_ $$2pmid$$apmid:33197097
000165932 0247_ $$2ISSN$$a0965-2140
000165932 0247_ $$2ISSN$$a1360-0443
000165932 0247_ $$2altmetric$$aaltmetric:94583429
000165932 037__ $$aDKFZ-2020-02483
000165932 041__ $$aeng
000165932 082__ $$a610
000165932 1001_ $$0P:(DE-He78)d208b072fe4d2b13f6f1d3b319041c8a$$aGredner, Thomas$$b0$$eFirst author$$udkfz
000165932 245__ $$aImpact of reducing alcohol consumption through price-based policies on cancer incidence in Germany 2020 to 2050 - a simulation study.
000165932 260__ $$aOxford [u.a.]$$bWiley-Blackwell48833$$c2021
000165932 3367_ $$2DRIVER$$aarticle
000165932 3367_ $$2DataCite$$aOutput Types/Journal article
000165932 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1623232806_8163
000165932 3367_ $$2BibTeX$$aARTICLE
000165932 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000165932 3367_ $$00$$2EndNote$$aJournal Article
000165932 500__ $$a#EA:C070#LA:M050# / 2021 Jul;116(7):1677-1688
000165932 520__ $$aAlcohol is a major cancer risk factor and contributes considerably to the cancer burden in Germany. We aimed to provide projections of preventable cancer cases under different price-based alcohol policy scenarios.A macro-simulation approach was used to estimate numbers and proportions of cancer cases prevented under different price-based alcohol policy scenarios.Published price elasticities for main alcoholic beverages were applied to the mean daily intake of pure alcohol in the German population calculated from the 'German Health Interview and Examination Survey for Adults 2008-2011 (DEGS1) to obtain hypothetical exposure distributions of high alcohol consumption under different scenarios of changing price for alcoholic beverages.Age-, sex-, and cancer-site specific potential impact fractions were calculated for different scenarios of changing the price of alcohol (single price increases, repeated price increases, volumetric price increase) for each year of a 30-year study period (2020-2050).Over a 30-year horizon, an estimated 4.7% (men: 10.1%, women: 1.4%) of alcohol-related cancer cases could be prevented in Germany, if alcohol intake above risk thresholds were reduced to levels below risk thresholds. Accordingly, the burden of new cancers would be reduced by approximately 244,000 cases (men: 200,000, women: 44,000). Of all price-based alcohol policy scenarios, a 100% price increase on alcoholic beverages was estimated to be most effective with about 213,000 (4.1%; men: 167,000; women: 47,000) preventable alcohol-related cancer cases, followed by 5-yearly 25% price increases (2.8%; men: 115,000, women: 29,000), and a volumetric price increase according to the beverage-specific alcohol content (1.9%; men: 72,000, women: 24,000).Simulations suggest that a substantial number of alcohol-related cancer cases could be avoided in Germany by applying price-based policies to reduce consumption of alcoholic beverages.
000165932 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000165932 588__ $$aDataset connected to CrossRef, PubMed,
000165932 7001_ $$0P:(DE-He78)20dc4ad11ff465acf5b99f1e679e10b7$$aNiedermaier, Tobias$$b1$$udkfz
000165932 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b2$$udkfz
000165932 7001_ $$0P:(DE-He78)1b59582b6c05ac4e57aa8b90dd9667f9$$aMons, Ute$$b3$$eLast author$$udkfz
000165932 773__ $$0PERI:(DE-600)2002997-4$$a10.1111/add.15335$$gp. add.15335$$n7$$p1677-1688$$tAddiction$$v116$$x1360-0443$$y2021
000165932 909CO $$ooai:inrepo02.dkfz.de:165932$$pVDB
000165932 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d208b072fe4d2b13f6f1d3b319041c8a$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000165932 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)20dc4ad11ff465acf5b99f1e679e10b7$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000165932 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000165932 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1b59582b6c05ac4e57aa8b90dd9667f9$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000165932 9130_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000165932 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000165932 9141_ $$y2021
000165932 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2020-08-28$$wger
000165932 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2020-08-28$$wger
000165932 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-08-28
000165932 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-08-28
000165932 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-08-28
000165932 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-08-28
000165932 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-08-28
000165932 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2020-08-28
000165932 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-08-28
000165932 915__ $$0StatID:(DE-HGF)0130$$2StatID$$aDBCoverage$$bSocial Sciences Citation Index$$d2020-08-28
000165932 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-08-28
000165932 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-08-28
000165932 915__ $$0StatID:(DE-HGF)1180$$2StatID$$aDBCoverage$$bCurrent Contents - Social and Behavioral Sciences$$d2020-08-28
000165932 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bADDICTION : 2018$$d2020-08-28
000165932 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2020-08-28
000165932 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2020-08-28
000165932 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bADDICTION : 2018$$d2020-08-28
000165932 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000165932 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000165932 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000165932 9201_ $$0I:(DE-He78)M050-20160331$$kM050$$lM050 Krebsprävention$$x3
000165932 980__ $$ajournal
000165932 980__ $$aVDB
000165932 980__ $$aI:(DE-He78)C070-20160331
000165932 980__ $$aI:(DE-He78)C120-20160331
000165932 980__ $$aI:(DE-He78)HD01-20160331
000165932 980__ $$aI:(DE-He78)M050-20160331
000165932 980__ $$aUNRESTRICTED